---
title: "AGER"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene AGER"
tags: ['GeneAGER', 'RAGE', 'Diabetes', 'Alzheimers', 'Inflammation', 'DrugResponse', 'Prognosis', 'Mutation']
---

# Information about Gene AGER

## Gene Information
- Gene: **AGER**
- Function: Advanced glycosylation end product-specific receptor
- Genomic Location: Chr6:41,775,338-41,779,464
- Aliases: RAGE, AGER1, RAGER, AGE-R1, HMGB1R

## External IDs
- HGNC: 87
- NCBI Entrez Gene: 177
- Ensembl: ENSG00000103013
- OMIM: 600214
- UniProtKB/Swiss-Prot: Q15109

## AA Mutation list and mutation type with dbSNP ID
- No AA Mutations reported for gene AGER in dbSNP database

## Somatic SNVs/InDels with dbSNP ID
- No Somatic SNVs/InDels reported for gene AGER in dbSNP database

## Related Disease
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Inflammation
- Alzheimer's Disease

## Treatment and Prognosis
- Potential therapeutic strategies for AGER-associated diseases include the use of RAGE inhibitors, anti-inflammatory agents, and antioxidants.
- The prognosis for AGER-associated diseases depends on the specific disease and the stage of disease progression.

## Drug Response
- Studies have shown that anti-RAGE agents can help in treating and preventing AGER-associated diseases such as diabetes, Alzheimer's disease, and inflammation.

## Related Papers
- Subject: Role of the advanced glycation end product pathway in aging-related disease and frailty
  - Author: Semba RD, Nicklett EJ, Ferrucci L.
  - DOI: 10.1097/ACM.0b013e31812e4214

- Subject: Inhibition of RAGE signaling: Strategies for drug discovery.
  - Author: Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Nawroth P, Hofmann MA, Yan SF, D'Agati VD, Schmidt AM.
  - DOI: 10.1111/j.1742-4658.2008.06491.x

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**